Letteratura scientifica selezionata sul tema "Dépistages des cancers"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Dépistages des cancers".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Dépistages des cancers"
Launoy, Guy. "Cancer : les causes de l’augmentation du nombre de cas en France". Questions de santé publique, n. 4 (aprile 2009): 1–4. http://dx.doi.org/10.1051/qsp/2009004.
Testo completoDescamps, P., J. J. Baldauf e P. Bonnier. "Dépistages des cancers gynécologiques et mammaires". Journal de Gynécologie Obstétrique et Biologie de la Reproduction 33, n. 6 (ottobre 2004): 536. http://dx.doi.org/10.1016/s0368-2315(04)96573-8.
Testo completoCopin, N., G. Gusto, B. Royer, F. Devay, A. Ruiz e O. Lantieri. "Inégalités de recours aux dépistages des cancers". Revue d'Épidémiologie et de Santé Publique 61 (ottobre 2013): S314. http://dx.doi.org/10.1016/j.respe.2013.07.369.
Testo completoMoutel, Grégoire, Sylviane Darquy, Odile Jullian e Nathalie Duchange. "Éthique et dépistages organisés des cancers en France". Santé Publique S2, HS2 (2019): 67. http://dx.doi.org/10.3917/spub.197.0067.
Testo completoSampic, Maureen, Valérie Lépine e Pierre Mignot. "Communication et régionalisation des centres de dépistages des cancers". Communication et organisation, n. 63 (1 luglio 2023): 173–87. http://dx.doi.org/10.4000/communicationorganisation.12222.
Testo completoBloy, Géraldine, e Laurent Rigal. "En quête de pertinence et d’égalité ? Quand les prescriptions des dépistages des cancers gynécologiques s’emmêlent". Revue française des affaires sociales 1, n. 3 (2019): 11. http://dx.doi.org/10.3917/rfas.193.0011.
Testo completoSicsic, Jonathan, e Carine Franc. "Préférences des médecins généralistes vis-à-vis des mesures incitatives associées aux dépistages des cancers". Santé Publique S2, HS2 (2019): 33. http://dx.doi.org/10.3917/spub.197.0033.
Testo completoDawidowicz, S., J. Le Breton, V. Renard, S. Bercier, Z. Brixi, E. Audureau, P. Clerc, S. Bastuji-Garins e E. Ferrat. "Déterminants de non-participation des femmes aux trois dépistages des cancers du sein, du col et colo-rectal (étude « TRI-PTIC »)". Revue d'Épidémiologie et de Santé Publique 65, n. 2 (aprile 2017): 172. http://dx.doi.org/10.1016/j.respe.2017.01.109.
Testo completoHsairi, Mohamed, Heger Ben Gobrane, Nissaf Ben Alaya, Ridha Bellaaj e Noureddine Achour. "Connaissances et attitudes des étudiants en fin d'études médicales vis-à-vis des dépistages des cancers du col utérin et du sein". Santé Publique 19, n. 2 (2007): 119. http://dx.doi.org/10.3917/spub.072.0119.
Testo completoGOCKO, X. "PROPHETIE AUTOREALISATRICE ET DEPISTAGE DU CANCER DU POUMON". EXERCER 35, n. 204 (1 giugno 2024): 243. http://dx.doi.org/10.56746/exercer.2024.204.243.
Testo completoTesi sul tema "Dépistages des cancers"
Rigal, Laurent. "Dépistages des cancers gynécologiques en médecine générale - Variabilité des pratiques de soins". Phd thesis, Université Paris Sud - Paris XI, 2014. http://tel.archives-ouvertes.fr/tel-00956912.
Testo completoPornet, Carole. "Influence de l'environnement socioéconomique et de l'offre de soins sur la participation aux dépistages organisés des cancers du sein et du colon-rectum à l'aide d’un nouvel outil : the european deprivation index". Caen, 2013. http://www.theses.fr/2013CAEN3167.
Testo completoTo reduce social inequalities in health, the High Council of Public Health recommends measure precisely compare between different regions or countries, and track changes over time. The mechanisms underlying social inequalities in participation in organized screening for breast and colorectal cancer are unknown. The objective was to analyze the environmental impact of socioeconomic status and healthcare supply on participation in organized screening for these cancers with an ecological deprivation index, the French version of EDI. This work presents the construction of this adaptable European transnational index. EDI is composed of census variables that best reflect the individual experience of relative deprivation. The study on the comparison of eight indices as to their assessment of deprivation at the individual level, showed that the performance of EDI were similar to those of the British indices. Using EDI, our studies have shown that in the most deprived areas, participation in screening for breast and colorectal cancer was reduced by 13% and 25% compared to the least deprived areas. No influence of the healthcare supply as measured by the presence or absence of general practitioners or certified radiologists were found. Social inequalities in screening could be reduced by combining individual interventions and geographical approaches targeted at populations at risk of low participation socially identified, emphasizing the superiority of organized screening on individual testing and advocating the involvement of general practitioners
Rondet, Claire. "Déterminants socio-territoriaux de l'absence ou du retard de participation aux dépistages des cancers féminins. Impact de l'origine migratoire et du lien social. Une étude en population générale à partir des données de la cohorte SIRS". Thesis, Paris 6, 2016. http://www.theses.fr/2016PA066573/document.
Testo completoThis study inscribes itself in the general scheme of better knowing the social determinants of delayed or no lifetime participation of gynecological cancer screening. Social determinants here refer to the sociodemographic and psychosocial dimensions which can have an impact on this participation. We particularly looked at the impact of migration origin and social contact of women. Based on the data collected by the SIRS cohort study in 2010, this work leads to confirm the existence of an important social gradient with regard to the participation of women but leads to demonstrate that women of immigrant origin are in an intermediary position between French women born from two French parents and foreign women regarding the delayed or no lifetime participation on cancer screening. We also have showed the importance of social contact in this participation
Dugord, Clara. "Déterminants et transmission des comportements de recours à la prévention sur longue période". Electronic Thesis or Diss., Université Paris sciences et lettres, 2023. http://www.theses.fr/2023UPSLD040.
Testo completoThis thesis examines women's demand for preventive care, particularly cancer screenings, over a long period using data from the French E3N-Générations cohorts. We show that preventive health seeking behaviors are stable over time, with a strong effect of habit. Secondly, women who are less educated and more distant from the healthcare system are more likely to remain outside the use of preventive health services and to stop their use prematurely. Lastly, social inequalities in the uptake of cancer screening persist across generations, as a result of the transmission of preventive health seeking behaviors. By targeting more strongly women who do not seek preventive care, health policies could induce a spillover effect on the next generation, helping to reduce social inequalities in health
Oldrini, Guillaume. "Dépistage en IRM mammaire". Thesis, Université de Lorraine, 2017. http://www.theses.fr/2017LORR0282/document.
Testo completoBreast MRI has a prominent place in breast imaging. Its wider use is limited in particular by its cost and the limited number of machines. We have worked on several aspects of this problem. In a first step, we changed the positioning from procubitus to decubitus. This showed that the decubitus allowed a better topographic correlation of the lesions with the ultrasound and was better tolerated by the patients. In a second step, we studied the factors of reduction of the acquisition time via the sequences with high temporal resolution and an abbreviated protocol. These changes should make it easier for patients to access MRI, reduce costs while maintaining the same sensitivity and specificity values as the standard protocol
Demoor, Goldschmidt Charlotte. "Effets iatrogènes à long terme de la radiothérapie dans l’enfance : prédiction de risque et dépistage". Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS533/document.
Testo completoBackground: Today, the five-year survival rate of children with cancer in France is over 80%, which corresponds to more than 50,000 adults cured of pediatric cancer, but the prevalence of long-term complications exceeds 60% after a 30-year follow-up. In this thesis, we focused on two distinct health problems: one serious and fatal, which is the risk of secondary breast cancer - the other morbid, affecting quality of life and multifactorial, which is the risk of a small height in adulthood. Methods: The approach was different, essentially descriptive with field analysis, followed by intervention with the implementation of a national screening program in a targeted population for secondary breast cancer - and analytical with the development of a risk prediction model for small height risk in adulthood. The population studied was mainly that of the French FCCSS cohort, which are adults cured of childhood solid cancer and treated before 2000, with which some centres have joined for the breast cancer part. Results: Few women cured of childhood cancer and whose treatment included radiotherapy were screened (21.2% and 15.4% with radiological examinations). A significant proportion of infiltrating carcinomas were aggressive with 29% of triple negative tumors. On an intervention level, the DeNaCaPST program began 18 months ago and faced the problem of follow-up and transition of these survivors.Concerning the risk of small adult size, we were able to specify that low doses of radiotherapy received by the pituitary gland were a significant risk factor that this risk increased with the dose, that a large field on the spine was also an important parameter. Being small and being young at diagnostic of childhood cancer were two additional risk factors. In addition, we discovered the impact of two chemotherapy molecules from the alkylant family: busulfan and lomustine. Conclusion: Secondary breast cancers are reminiscent of those occurring in women with a BRCA constitutional mutation (age of onset, cumulative incidence at 50 years, aggressiveness of cancers, bilaterality rate), which justified the development of a national program, inspired by that for women at high risk due to a genetic mutation so that "equal risk, equal screening". The necessary care network is gradually being set up, requiring several amendments to the program. Regarding the risk of small height in adulthood, further studies are needed to confirm our findings
Moshyk, Andriy. "Dépistage du cancer de la prostate analyse décisionnelle". Mémoire, Université de Sherbrooke, 2004. http://savoirs.usherbrooke.ca/handle/11143/3813.
Testo completoSévilla, Christine. "Evaluation économique des innovations biomédicales : l'exemple de la diffusion des tests génétiques en oncologie". Paris, EHESS, 2003. http://www.theses.fr/2003EHES0045.
Testo completoThe localisation and the identification of two breast/ovarian cancer susceptibility genes, BRCA1 and BRCA2, have made it possible the introduction of genetic testing for predisposition to these cancers in new medical practices, intended for at risk persons identified on the basis of their idividual and familial characteristics. The objective of this work is to study the diffusion of this brand-new biomedical innovation and the difficulties it generates. After having presented the general factors of the diffusion of innovations identified by the economic theory, on the supply side and on the demand side, we present the problem posed by the genetic testing : we show how the diffusion of these tests poses some difficulties related to the general factors of diffusion or to problems more specific to activities of predictive medicine, but also how the resolution of some difficulties necessitates the adoption of a normative approach
Guedaoura, Sonya. "Pratiques de dépistage du cancer des femmes non porteuses de mutations familiales des gènes BRCA1/2". Master's thesis, Université Laval, 2017. http://hdl.handle.net/20.500.11794/27686.
Testo completoMarty, Maryse. "Cancer du col : dépistage et dysplasies : thèse audio-visuelle". Montpellier 1, 1992. http://www.theses.fr/1992MON11059.
Testo completoLibri sul tema "Dépistages des cancers"
Guillot, Bernard. Dépistage et cancers cutanés. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-71050-6.
Testo completoTubiana-Mathieu, N. Cancers: Prévention et dépistage. Paris: Masson, 2002.
Cerca il testo completoJean-Jacques, Baldauf, Bonnier Pascal e Collège national des gynécologues et obstétriciens français., a cura di. Dépistage des cancers gynécologiques et mammaires. Paris: Masson, 2004.
Cerca il testo completoH, Sancho-Garnier, a cura di. Dépistage des cancers: De la médecine à la santé publique. Paris: Éditions INSERM, 1997.
Cerca il testo completoGompel, Claude. Dépistage du cancer du col utérin: Pourquoi chaque année 500,000 femmes meurent de ce cancer dans le monde? Paris: Maloine, 2005.
Cerca il testo completoSéradour, Brigitte. Le dépistage du cancer du sein: un enjeu de santé publique. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39695-3.
Testo completoGroup, Canada Health Canada Evaluation Indicators Working. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. [Ottawa]: Health Canada, 2002.
Cerca il testo completoPublic Health Agency of Canada. Centre for Chronic Disease Prevention and Control e Agence de santé publique du Canada. Centre de prévention et de contrôle des maladies chroniques, a cura di. Report from the evaluation indicators working group: Guidelines for monitoring breast screening program performance = Rapport du groupe de travail sur les indicateurs d'évaluation : lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein. 2a ed. [Ottawa, Ont.]: Public Health Agency of Canada = Agence de santé publique du Canada, 2007.
Cerca il testo completoCanada. Health Canada. Evaluation Indicators Working Group. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. 2a ed. [Ottawa]: Public Health Agency of Canada, 2007.
Cerca il testo completoNoorani, Hussein Zafer. Predictive genetic testing for breast and prostate cancer. Ottawa, Ont: Canadian Coordinating Office for Health Technology Assessment, 1999.
Cerca il testo completoCapitoli di libri sul tema "Dépistages des cancers"
Le Maître, M., e R. Delaveyne. "Diagnostic précoce ou dépistage du mélanome : un choix stratégique". In Dépistage et cancers cutanés, 67–80. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-71050-6_7.
Testo completoDigabel-Chabay, C., C. Quinzin e C. Allioux. "La mammographie de dépistage". In Le dépistage du cancer du sein: un enjeu de santé publique, 87–98. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39695-3_6.
Testo completoBorisch, B. "Informations aux patientes pour le dépistage par mammographie". In Cancer du sein : surdiagnostic, surtraitement, 53–56. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_5.
Testo completoLemarié, E. "Épidémiologie, facteurs de risque, dépistage des cancers broncho-pulmonaires". In Oncologie thoracique, 17–31. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-287-99041-0_2.
Testo completoCeugnart, L., S. Taieb e P. Vennin. "Dépistage et surdiagnostic : sommes-nous victimes du progrès technologique?" In Cancer du sein : surdiagnostic, surtraitement, 44–52. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_4.
Testo completoFracheboud, J., R. de Gelder, G. Draisma, E. Heijnsdijk e H. J. de Koning. "Le dépistage est-il responsable du surdiagnostic? Comment le mesurer?" In Cancer du sein : surdiagnostic, surtraitement, 40–43. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_3.
Testo completoVandenbroucke, A., T. De Foy e M. Candeur. "Programme de dépistage du cancer du sein et densité mammaire". In Cancer du sein : surdiagnostic, surtraitement, 336–38. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_98.
Testo completoAncelle-Park, R. "Ľévaluation du programme de dépistage du cancer du sein". In Le dépistage du cancer du sein: un enjeu de santé publique, 147–56. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39695-3_10.
Testo completoSancho-Garnier, H. "Principles généraux du dépistage: application au cancer du sein". In Le dépistage du cancer du sein: un enjeu de santé publique, 53–62. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39695-3_3.
Testo completoAncelle-Park, R. "Le dépistage organisé des cancers du sein, 20 ans après: Bénéfices et controverses". In Cancer du sein, 197–202. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_15.
Testo completoAtti di convegni sul tema "Dépistages des cancers"
Lan, R., F. Campana, J. H. Catherine, U. Ordioni e D. Tardivo. "Nouvelles techniques d’aide au diagnostic des lésions pré-cancéreuses et cancéreuses de la cavité orale : revue systématique et résultats préliminaires". In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602018.
Testo completoDenis, B., I. Gendre, S. Weber e P. Perrin. "Complications des coloscopies du programme de dépistage organisé du cancer colorectal par test immunologique: une étude de cohorte en population". In Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680851.
Testo completoDenis, B., I. Gendre, J. Lacroute e P. Perrin. "Traitement des polypes colorectaux bénins de 20 mm et plus du programme de dépistage organisé du cancer colorectal par test immunologique". In Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1623322.
Testo completoExbrayat, C., A. Seigneurin e P. Jennings. "Taux de détection des adénomes et risque de cancer d'intervalle après coloscopie dans le programme français de dépistage organisé en Isère de 2002 – 2013". In Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1623395.
Testo completoNoel, C., J. Jézéquel, F. Cholet, F. Bommelaere, S. Bouzeloc, M. Cariou, JB Nousbaum e M. Robaszkiewicz. "Analyse des comptes-rendus de coloscopie établis sur une année dans le cadre du programme de dépistage organisé du cancer colorectal dans un département français". In Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680865.
Testo completoKharmach, O., I. Benelbarhdadi e FZ Ajana. "La coloscopie standard avec biopsies étagées a-t-elle toujours une place dans le dépistage des dysplasies et du cancer colorectal au cours de MICI?" In Journées Francophones d'Hépato-Gastroentérologie et d'Oncologie Digestive (JFHOD). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680987.
Testo completoRapporti di organizzazioni sul tema "Dépistages des cancers"
Corkum, Eleanor, Tiffanie Perrault e Erin C. Strumpf. Améliorer les parcours de diagnostic du cancer du sein au Québec. CIRANO, ottobre 2023. http://dx.doi.org/10.54932/tlak9928.
Testo completo